+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Contact Lenses Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 161 Pages
  • September 2024
  • Region: Global
  • GlobalData
  • ID: 5693518
The Medical Devices sector report, “Contact Lenses Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Contact Lenses pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Contact Lenses is a corrective, cosmetic or therapeutic lens which is placed on the cornea of the eye.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Contact Lenses under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Contact Lenses and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Contact Lenses under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Contact Lenses Overview
3 Products under Development
3.1 Contact Lenses - Pipeline Products by Stage of Development
3.2 Contact Lenses - Pipeline Products by Segment
3.3 Contact Lenses - Pipeline Products by Territory
3.4 Contact Lenses - Pipeline Products by Regulatory Path
3.5 Contact Lenses - Pipeline Products by Estimated Approval Date
3.6 Contact Lenses - Ongoing Clinical Trials
4 Contact Lenses - Pipeline Products under Development by Companies
4.1 Contact Lenses Companies - Pipeline Products by Stage of Development
4.2 Contact Lenses - Pipeline Products by Stage of Development
5 Contact Lenses Companies and Product Overview6 Contact Lenses- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Contact Lenses - Pipeline Products by Stage of Development
  • Contact Lenses - Pipeline Products by Segment
  • Contact Lenses - Pipeline Products by Territory
  • Contact Lenses - Pipeline Products by Regulatory Path
  • Contact Lenses - Pipeline Products by Estimated Approval Date
  • Contact Lenses - Ongoing Clinical Trials
  • Contact Lenses Companies - Pipeline Products by Stage of Development
  • Contact Lenses - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Contact Lenses - Pipeline Products by Stage of Development
  • Contact Lenses - Pipeline Products by Segment
  • Contact Lenses - Pipeline Products by Territory
  • Contact Lenses - Pipeline Products by Regulatory Path
  • Contact Lenses - Pipeline Products by Estimated Approval Date
  • Contact Lenses - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aeon Astron Corporation
  • Ai Kangte Medical Technology Co Ltd
  • Alcon Inc
  • Alcon Laboratories Inc
  • Apeliotus Ophthalmics (Inactive)
  • Axcelon Biopolymers Corp
  • Azalea Vision
  • Bar-Ilan University
  • Bausch & Lomb Inc
  • Bionode LLC
  • Body Organ Biomedical Corp
  • BVS Sight Inc
  • Chinese Academy of Sciences
  • Clerio Vision Inc
  • Diopter Technologies Inc (Inactive)
  • Euclid Systems Corp
  • e-Vision Medical Devices, Inc.
  • Eyenovations
  • EyeYon Medical
  • Fitlens Ltd
  • iCheck LLC
  • Imperial College London
  • Industrial Science & Technology Network Inc
  • Innovega Inc
  • Johnson & Johnson Vision Care Inc
  • Khalifa University
  • Kubota Vision Inc
  • Lentechs LLC
  • Lipocoat BV
  • Lynthera Corp
  • Massachusetts Eye and Ear Infirmary
  • McGowan Institute for Regenerative Medicine
  • Mojo Vision Inc
  • National University of Singapore
  • Novartis AG
  • Ocular Dynamics, LLC
  • Ocutec Ltd
  • PHI Biomed Co Ltd
  • Purdue University
  • Queen's University
  • RetMap Inc
  • Shamir Optical Industry Ltd
  • Smartlens Inc
  • Stanford University
  • SynergEyes Inc
  • TECLens LLC
  • Terasaki Institute for Biomedical Innovation
  • The University of New South Wales press Limited
  • University of California
  • University of California Irvine
  • University of California San Diego
  • University of New Hampshire
  • University of Valencia
  • University of Washington
  • Visioneering Technologies Inc
  • VISTAKON Pharmaceuticals LLC
  • XPANCEO Research On Natural Science LLC